BioCV Denmark ApS: Financial statements 2022
CVR: 43088742
Source: annual report 2022, Danish Business Authority
25/02/2022 – 31/12/2022
BioCV Denmark ApS (CVR 43088742) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -28,183 and a net result of DKK -28,518. Equity in the 2022 report amounted to DKK 11,482. The solvency ratio was 34.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -28,183
- Profit/Loss
- DKK -28,518
- Equity
- DKK 11,482
- Total Assets
- DKK 33,705
- Employees
- 1
Official annual report
Keep an eye on BioCV Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of February 25, 2022, Moritz Marvin Gansel is registered as director of BioCV Denmark ApS.
As of February 25, 2022, is registered as an owner of BioCV Denmark ApS with an ownership share of 100%.
BioCV Denmark ApS was founded on February 25, 2022.
About BioCV Denmark ApS
BioCV Denmark ApS is a Danish company of the type Anpartsselskab based in Tjele, founded in 2022. The company is registered under the industry Computerprogrammering. The management consists of Moritz Marvin Gansel. The company is owned by BioCV GmbH. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -386,126 and a net result of DKK -585,336 compared with DKK -666,047 the year before. Equity in the 2025 report amounted to DKK -1,292,859.